India, Sept. 22 -- Mumbai-based B2B healthtech marketplace Medikabazaar is raising INR 433 Cr from a clutch of investors. UK-based CDC Group, Rebright Ventures are participating in this round of funding.

According to the regulatory filings accessed by Inc42, Medikabazaar is allotting 6,38,357 Series C Compulsory Convertible Preference Shares at a premium of INR 6787.22 to ten investors.

The new funding round which seems to be its Series C round will see participation of UK-based development finance institution CDC group which will be infusing a total of INR 131 Cr in exchange for 1,93,350 Series C CCPS.

Startup's existing investor Rebright Ventures will be pumping in INR 15 Cr and MSIVC Venture Capital will pump INR 30 Cr. Angel invest...